Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:1917

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2005;112:1917.)
© 2005 American Heart Association, Inc.

Issue Highlights


*    EFFECT OF FISH OIL ON HEART RATE IN HUMANS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS, by Mozaffarian et al.
up arrowTop
*EFFECT OF FISH OIL...
down arrowCOMPARISON OF PERCUTANEOUS...
down arrowCOLCHICINE IN ADDITION TO...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
Heart rate is determined by the complex interplay of sympathetic and parasympathetic stimulation with sinus node automaticity. Faster heart rates are associated with increasing mortality and cardiovascular risk, consistent with the observations that increased sympathetic tone activation is not only a marker of risk but also has direct adverse effects. ß-Adrenergic-blocking agents and physical conditioning slow the heart rate and are beneficial. Mozaffarian and colleagues show that consumption of fish oil also slows heart rate. In a meta-analysis of randomized trials including 1678 subjects who ingested fish oil for 4 to 52 weeks, heart rate slowed by 1.6 beats per minute. Whether this is mediated by an alteration in cardiac lipid membranes that affects ion channel function, as has been previously hypothesized, or a reduction in sympathetic tone through some other mechanism remains to be established. The findings suggest potential mechanisms for cardiovascular benefits of fish or fish oil consumption. See p 1945.


*    COMPARISON OF PERCUTANEOUS CORONARY INTERVENTION AND CORONARY ARTERY BYPASS GRAFTING AFTER ACUTE MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK: RESULTS FROM THE SHOULD WE EMERGENTLY REVASCULARIZE OCCLUDED CORONARIES FOR CARDIOGENIC SHOCK (SHOCK) TRIAL, by White et al.
up arrowTop
up arrowEFFECT OF FISH OIL...
*COMPARISON OF PERCUTANEOUS...
down arrowCOLCHICINE IN ADDITION TO...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
Despite advances in reperfusion therapies, the incidence of cardiogenic shock has not changed, and it remains the most common cause of death in patients hospitalized with acute myocardial infarction. In the SHOCK trial, emergency revascularization, as compared with medical stabilization, resulted at 1 year in 130 lives saved per 1000 patients. Furthermore, most survivors had a good quality of life. To achieve this result, almost 40% of patients had emergency revascularization surgery. The SHOCK investigation compared the outcomes according to choice of PCI or CABG, which was done by site investigators. Patients treated with CABG had a greater prevalence of diabetes and more advanced coronary diseases than did patients treated with PCI. However, survival rates at 12 months were similar. See p 1992.


*    COLCHICINE IN ADDITION TO CONVENTIONAL THERAPY FOR ACUTE PERICARDITIS: RESULTS OF THE COPE TRIAL, by Imazio et al.
up arrowTop
up arrowEFFECT OF FISH OIL...
up arrowCOMPARISON OF PERCUTANEOUS...
*COLCHICINE IN ADDITION TO...
down arrowCardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
The treatment of acute pericarditis is based predominantly on observational data. For the problematic group of patients with recurrent symptoms of pericarditis after the initial episode, some studies have suggested colchicine to be effective. In this issue of Circulation, Imazio and colleagues report the results of a prospective, randomized trial of colchicine in patients with acute pericarditis. Over 18 months of follow-up, the rate of recurrent symptoms was reduced by 70%. Moreover, colchicine therapy started during the acute episode resulted in more rapid resolution of the initial symptoms. These data provide an evidence base that can inform therapeutic decisions for clinicians in the treatment of acute pericarditis. See p 2012.

Visit http://www.circ.ahajournals.org:


*    Cardiology Patient Page
up arrowTop
up arrowEFFECT OF FISH OIL...
up arrowCOMPARISON OF PERCUTANEOUS...
up arrowCOLCHICINE IN ADDITION TO...
*Cardiology Patient Page
down arrowImages in Cardiovascular...
down arrowCorrespondence
 
Cardiac Resynchronization Therapy: A Better and Longer Life for Patients With Advanced Heart Failure. See p e236.


*    Images in Cardiovascular Medicine
up arrowTop
up arrowEFFECT OF FISH OIL...
up arrowCOMPARISON OF PERCUTANEOUS...
up arrowCOLCHICINE IN ADDITION TO...
up arrowCardiology Patient Page
*Images in Cardiovascular...
down arrowCorrespondence
 
Development of a Cardiac Neocavity After Mechanic Double-Valve Replacement: Evaluation by Cardiac Magnetic Resonance Imaging. See p e238.

Periaortic Valve Abscess Presenting as Unstable Angina. See p e240.



View larger version (122K):
[in this window]
[in a new window]
 

Late Enhancement of a Left Ventricular Cardiac Fibroma Assessed With Gadolinium-Enhanced Cardiovascular Magnetic Resonance. See p e242.


*    Correspondence
up arrowTop
up arrowEFFECT OF FISH OIL...
up arrowCOMPARISON OF PERCUTANEOUS...
up arrowCOLCHICINE IN ADDITION TO...
up arrowCardiology Patient Page
up arrowImages in Cardiovascular...
*Correspondence
 
See p e244.


Related Articles:

Comparison of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting After Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results From the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial
Harvey D. White, Susan F. Assmann, Timothy A. Sanborn, Alice K. Jacobs, John G. Webb, Lynn A. Sleeper, Cheuk-Kit Wong, James T. Stewart, Philip E.G. Aylward, Shing-Chiu Wong, and Judith S. Hochman
Circulation 2005 112: 1992-2001. [Abstract] [Full Text]

Colchicine in Addition to Conventional Therapy for Acute Pericarditis: Results of the COlchicine for acute PEricarditis (COPE) Trial
Massimo Imazio, Marco Bobbio, Enrico Cecchi, Daniela Demarie, Brunella Demichelis, Franco Pomari, Mauro Moratti, Gianni Gaschino, Massimo Giammaria, Aldo Ghisio, Riccardo Belli, and Rita Trinchero
Circulation 2005 112: 2012-2016. [Abstract] [Full Text]

Cardiac Resynchronization Therapy: A Better and Longer Life for Patients With Advanced Heart Failure
Srinivas Iyengar and William T. Abraham
Circulation 2005 112: e236-e237. [Full Text]

Development of a Cardiac Neocavity After Mechanic Double-Valve Replacement: Evaluation by Cardiac Magnetic Resonance Imaging
Achim Barmeyer, Kai Muellerleile, Gunnar K. Lund, Alexander Stork, Nils Gosau, Andreas Koops, Sebastian Gehrmann, Thomas Hofmann, Ditmar H. Koschyk, Claus Nolte-Ernsting, Gerhard Adam, and Thomas Meinertz
Circulation 2005 112: e238-e239. [Full Text]

Periaortic Valve Abscess Presenting as Unstable Angina
Giampaolo Zoffoli and Tiziano Gherli
Circulation 2005 112: e240-e241. [Full Text]

Late Enhancement of a Left Ventricular Cardiac Fibroma Assessed With Gadolinium-Enhanced Cardiovascular Magnetic Resonance
Francesco De Cobelli, Antonio Esposito, Renata Mellone, Marco Papa, Tiziana Varisco, Roberto Besana, and Alessandro del Maschio
Circulation 2005 112: e242-e243. [Full Text]

Letter Regarding Article by Sega et al, "Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population" Response
Tine Willum Hansen, Jørgen Jeppesen, Hans Ibsen, Eamon Dolan, Eoin T. O’Brien, Jan A. Staessen, Takayoshi Ohkubo, Yutaka Imai, Roberto Sega, Rita Facchetti, Michele Bombelli, Giancarlo Cesana, Giovanni Corrao, Guido Grassi, and Giuseppe Mancia
Circulation 2005 112: e244-e246. [Full Text]

Effect of Fish Oil on Heart Rate in Humans: A Meta-Analysis of Randomized Controlled Trials
Dariush Mozaffarian, Anouk Geelen, Ingeborg A. Brouwer, Johanna M. Geleijnse, Peter L. Zock, and Martijn B. Katan
Circulation 2005 112: 1945-1952. [Abstract] [Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles